HomeCompareTPHIF vs JNJ

TPHIF vs JNJ: Dividend Comparison 2026

TPHIF yields 110.50% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TPHIF wins by $5.90M in total portfolio value
10 years
TPHIF
TPHIF
● Live price
110.50%
Share price
$1.81
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.93M
Annual income
$2,132,830.87
Full TPHIF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — TPHIF vs JNJ

📍 TPHIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTPHIFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TPHIF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TPHIF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TPHIF
Annual income on $10K today (after 15% tax)
$9,392.27/yr
After 10yr DRIP, annual income (after tax)
$1,812,906.24/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, TPHIF beats the other by $1,808,920.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TPHIF + JNJ for your $10,000?

TPHIF: 50%JNJ: 50%
100% JNJ50/50100% TPHIF
Portfolio after 10yr
$2.98M
Annual income
$1,068,760.14/yr
Blended yield
35.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TPHIF
No analyst data
Altman Z
0.5
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TPHIF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTPHIFJNJ
Forward yield110.50%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$5.93M$30.3K
Annual income after 10y$2,132,830.87$4,689.40
Total dividends collected$5.35M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TPHIF vs JNJ ($10,000, DRIP)

YearTPHIF PortfolioTPHIF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$21,750$11,049.72$10,592$272.30+$11.2KTPHIF
2$45,733$22,460.60$11,289$357.73+$34.4KTPHIF
3$93,072$44,137.91$12,123$472.89+$80.9KTPHIF
4$183,537$83,949.70$13,141$629.86+$170.4KTPHIF
5$351,102$154,717.47$14,408$846.81+$336.7KTPHIF
6$652,287$276,608.54$16,021$1,151.60+$636.3KTPHIF
7$1,178,220$480,272.57$18,122$1,588.22+$1.16MTPHIF
8$2,071,454$810,758.34$20,930$2,228.20+$2.05MTPHIF
9$3,548,616$1,332,160.25$24,792$3,191.91+$3.52MTPHIF
10$5,929,850$2,132,830.87$30,274$4,689.40+$5.90MTPHIF

TPHIF vs JNJ: Complete Analysis 2026

TPHIFStock

Top Frontier Investment Holdings, Inc., together with its subsidiaries, engages in the food and beverage, packaging, energy, mining, fuel and oil, infrastructure, cement, and real estate property management and development businesses worldwide. It offers poultry, fresh meat, and refrigerated and canned meat products; butter, margarine, cheese, milk, ice cream, jelly-based snacks and desserts, specialty oils, salad aids, and snacks and condiments; flour mixes; flour and bakery ingredients; and coffee and related products. The company also offers feeds; poultry and livestock farming; grain terminal handling; and food services, as well as fermented, malt-based, and non-alcoholic beverages; liquor, Chinese wine, brandy, rum, vodka, and other liquor products; and value-added refrigerated meats, such as hotdogs, nuggets, bacon, hams, ready-to-heat meal, seafood lines, and meat free products, as well as operates franchises. In addition, it offers glass containers and molds, polyethylene terephthalate (PET) bottles and preforms, PET recycling, plastic closures, corrugated cartons, woven polypropylene, kraft sacks and paperboards, pallets, flexible packaging, plastic crates, plastic floorings, plastic films, plastic trays, plastic pails and tubs, metal closures and two-piece aluminum cans, woven products, and industrial laminates and radiant barriers; and crate and plastic pallet leasing, PET bottle filling graphics design, packaging research and testing, packaging development and consultation, and contract packaging and trading services. Further, it sells, retails, and distributes power; refines and markets petroleum products; develops and constructs toll roads, airports, railways, and bulk water. Additionally, it explores, develops, and utilizes nickel, cobalt, chrome, iron, gold, and other mineral deposits; produces and sells cement; and develops, sells, and leases real properties. The company was incorporated in 2008 and is headquartered in Makati City, the Philippines.

Full TPHIF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this TPHIF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TPHIF vs SCHDTPHIF vs JEPITPHIF vs OTPHIF vs KOTPHIF vs MAINTPHIF vs ABBVTPHIF vs MRKTPHIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.